Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
about
Effect of vaccine administration modality on immunogenicity and efficacy.Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsRatio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγExpression of nucleic acid-sensing Toll-like receptors predicts HPV16 clearance associated with an E6-directed cell-mediated responseLocal administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation.Targeted treatments for cervical cancer: a review.A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).New Approaches to Immunotherapy for HPV Associated Cancers.Immunologic treatments for precancerous lesions and uterine cervical cancer.Modes of action of TLR7 agonists in cancer therapy.Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Factors associated with equine aural plaque in Brazil.Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.Genital warts treatment: Beyond imiquimod.Emerging human papillomavirus vaccinesTrends in Biosensors for HPV: Identification and Diagnosis
P2860
Q27692376-1D49D9F8-A742-4400-85F3-0CF71D9D9ED0Q28076161-26664D17-5953-4F69-8FF1-0B396E7F95B0Q34142500-F3B891A0-E72C-43AE-AD96-5FF704F92235Q34438411-B5B2FB12-A270-4850-B6AD-79013F63D57AQ35164128-64DE13A7-335B-4959-8E8D-2E822EA8ED9BQ35181633-584B06B5-BD4D-4973-A164-8CE44C07B95BQ36384032-135BB613-3F13-4646-8845-12199A203211Q36494733-13764ABA-6D84-4993-9499-2FA58A7D06EAQ37137430-C0082DE3-E2B6-4BDD-BEAE-84014886A3D6Q37703113-FE93128D-8581-4BB3-AFCE-4A6CF97B8C0AQ38271879-55564D87-8840-4364-8CA4-D80B633E611CQ38342834-3AD1532D-CFC4-486F-BC79-CAF29CB41DCCQ38370782-45FC8390-58A6-4563-ADFB-0C5E06AB8B5BQ39601328-0FF46611-0166-492F-B60D-D8530A8A2CFEQ42235064-D16C95D5-212B-4EB7-8BA0-A10BA18DE371Q50115667-0D568F9D-2060-4320-8A48-BEFE68C0C197Q54262209-CF6AF061-ABEA-4005-A53A-00D3E680F518Q56967486-DF805942-6E02-4FDF-AADD-E6FE371FE16EQ59114620-594D0376-D859-4B45-9396-81EC1AB95D10
P2860
Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment with imiquimod enhan ...... herapeutic HPV DNA vaccination
@ast
Treatment with imiquimod enhan ...... herapeutic HPV DNA vaccination
@en
type
label
Treatment with imiquimod enhan ...... herapeutic HPV DNA vaccination
@ast
Treatment with imiquimod enhan ...... herapeutic HPV DNA vaccination
@en
prefLabel
Treatment with imiquimod enhan ...... herapeutic HPV DNA vaccination
@ast
Treatment with imiquimod enhan ...... herapeutic HPV DNA vaccination
@en
P2093
P2860
P356
P1476
Treatment with imiquimod enhan ...... herapeutic HPV DNA vaccination
@en
P2093
Archana Monie
Chi-Mu Chuang
Chien-Fu Hung
P2860
P2888
P356
10.1186/1423-0127-17-32
P577
2010-04-28T00:00:00Z
P5875
P6179
1015721090